| Sep 7, 2018 |
Sep 10, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+15,000,000
|
18.76%
|
✗
|
$25M |
| Mar 26, 2018 |
Mar 28, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
97.5
|
+6,571,164
|
8.95%
|
✗
|
$12.6M |
| Mar 21, 2018 |
Mar 23, 2018 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
87.5
|
+1,268,508
|
1.76%
|
✗
|
$2.4M |
| Feb 26, 2018 |
Feb 27, 2018 |
Oruka Therapeutics, Inc.
|
10% Owner |
Sell |
20.0
|
-1,460,209
|
-100.00%
|
✗
|
$731.3K |
| Nov 27, 2017 |
Nov 27, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-569,620
|
-100.00%
|
✗
|
$11.1M |
| Nov 20, 2017 |
Nov 21, 2017 |
APPIAN CORP
|
10% Owner |
Sell |
15.0
|
-2,820,516
|
-100.00%
|
✗
|
$55M |
| Oct 10, 2017 |
Oct 10, 2017 |
RHYTHM PHARMACEUTICALS, INC.
|
10% Owner |
Buy |
100.0
|
+550,000
|
12.61%
|
✗
|
$9.4M |
| Jul 3, 2017 |
Jul 6, 2017 |
Mersana Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
14.01%
|
✗
|
$15M |
| Mar 27, 2017 |
Mar 28, 2017 |
Adaptimmune Therapeutics PLC
|
10% Owner |
Buy |
100.0
|
+12,870,000
|
21.71%
|
✗
|
$9M |
| Jul 18, 2016 |
Jul 20, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+1,527,301
|
40.15%
|
✗
|
$13.3M |
| Jan 13, 2016 |
Jan 14, 2016 |
ARDELYX, INC.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
35.67%
|
✗
|
$10M |
| Oct 5, 2015 |
Oct 6, 2015 |
SYNLOGIC, INC.
|
10% Owner |
Buy |
100.0
|
+1,146,308
|
21.08%
|
✗
|
$6M |
| Jan 15, 2014 |
Jan 15, 2014 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
100.0
|
+512,500
|
14.31%
|
✗
|
$4.1M |